Cargando…

Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products

Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-Houssini, Ola M., Zawilla, Nagwan H., Mohammad, Mohammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795519/
https://www.ncbi.nlm.nih.gov/pubmed/24137049
http://dx.doi.org/10.4137/ACI.S12478
_version_ 1782287385476726784
author EL-Houssini, Ola M.
Zawilla, Nagwan H.
Mohammad, Mohammad A.
author_facet EL-Houssini, Ola M.
Zawilla, Nagwan H.
Mohammad, Mohammad A.
author_sort EL-Houssini, Ola M.
collection PubMed
description Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column and gradient mobile phase was applied for good resolution of all peaks. The detection was achieved at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The responses were linear over concentration ranges of 20–200, 20–1000 and 25–1000 μgmL(−1) for Cinn, Pira, and Hept respectively. The proposed method was validated for linearity, accuracy, repeatability, intermediate precision, and robustness via statistical analysis of the data. The method was shown to be precise, accurate, reproducible, sensitive, and selective for the analysis of Cinn/Pira and Cinn/Hept in laboratory prepared mixtures and in pharmaceutical formulations.
format Online
Article
Text
id pubmed-3795519
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-37955192013-10-17 Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products EL-Houssini, Ola M. Zawilla, Nagwan H. Mohammad, Mohammad A. Anal Chem Insights Original Research Specific stability indicating reverse-phase liquid chromatography (RP-LC) assay method (SIAM) was developed for the determination of cinnarizine (Cinn)/piracetam (Pira) and cinnarizine (Cinn)/heptaminol acefyllinate (Hept) in the presence of the reported degradation products of Cinn. A C(18) column and gradient mobile phase was applied for good resolution of all peaks. The detection was achieved at 210 nm and 254 nm for Cinn/Pira and Cinn/Hept, respectively. The responses were linear over concentration ranges of 20–200, 20–1000 and 25–1000 μgmL(−1) for Cinn, Pira, and Hept respectively. The proposed method was validated for linearity, accuracy, repeatability, intermediate precision, and robustness via statistical analysis of the data. The method was shown to be precise, accurate, reproducible, sensitive, and selective for the analysis of Cinn/Pira and Cinn/Hept in laboratory prepared mixtures and in pharmaceutical formulations. Libertas Academica 2013-10-07 /pmc/articles/PMC3795519/ /pubmed/24137049 http://dx.doi.org/10.4137/ACI.S12478 Text en © 2013 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article published under the Creative Commons CC-BY-NC 3.0 license.
spellingShingle Original Research
EL-Houssini, Ola M.
Zawilla, Nagwan H.
Mohammad, Mohammad A.
Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title_full Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title_fullStr Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title_full_unstemmed Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title_short Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
title_sort development and validation of rp-lc method for the determination of cinnarizine/piracetam and cinnarizine/heptaminol acefyllinate in presence of cinnarizine reported degradation products
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795519/
https://www.ncbi.nlm.nih.gov/pubmed/24137049
http://dx.doi.org/10.4137/ACI.S12478
work_keys_str_mv AT elhoussiniolam developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts
AT zawillanagwanh developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts
AT mohammadmohammada developmentandvalidationofrplcmethodforthedeterminationofcinnarizinepiracetamandcinnarizineheptaminolacefyllinateinpresenceofcinnarizinereporteddegradationproducts